News from NeuroSigma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 06, 2015, 07:00 ET FDA Grants NeuroSigma Humanitarian Use Device (HUD) Designation

NeuroSigma®, Inc. (NeuroSigma) today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug...


Jan 05, 2015, 07:00 ET UCLA Launches Phase II Pediatric Clinical Trial for the Treatment of ADHD with NeuroSigma's eTNS System

 NeuroSigma®, Inc. (NeuroSigma) today announced that enrollment has commenced for a 90-subject Phase II pediatric clinical trial of its...


Nov 19, 2014, 07:00 ET NeuroSigma Congratulates Brazilian Medical Team for Their Top-Line Results in Phase II Clinical Trial of eTNS for Treatment of Depression

 NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive external...


Oct 21, 2014, 07:00 ET NeuroSigma Receives Notice of Allowance of U.S. Patent Application

LOS ANGELES, Oct. 21, 2014 /PRNewswire/ – NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company focused on...


Jul 22, 2014, 07:00 ET Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome

 NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™...


Mar 28, 2014, 07:00 ET NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives

 NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™...


Jan 21, 2014, 05:00 ET External Trigeminal Nerve Stimulation (eTNS) Presentations at the American Epilepsy Society Meeting

 NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company, today announced that two presentations were made last month at the...


Dec 05, 2013, 07:00 ET NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Epilepsy and other Neurological Disorders

 NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company, announced today that the U.S. Patent and Trademark Office...


Jun 06, 2013, 07:00 ET NeuroSigma Launches Dedicated Website to Introduce Its Monarch eTNS System for Epilepsy and Depression

 NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the...


May 20, 2013, 17:00 ET Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)

Today, at the American Psychiatric Association (APA) Meeting in San Francisco, James McGough, M.D., M.S., principal investigator and Professor of...


Jan 22, 2013, 07:00 ET NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders

NeuroSigma, Inc., a California -based medical device company, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice...


Sep 06, 2012, 03:01 ET NeuroSigma erhält CE-Kennzeichnung

- Vorbereitung der Einführung von eTNS in Europa im vierten Quartal 2012; nicht invasive Behandlungsmethode gegen Epilepsie und Depression...


Sep 05, 2012, 18:56 ET NeuroSigma reçoit la certification CE

- Préparation du quatrième trimestre 2012 pour le lancement européen d'eTNS, traitement non-invasif contre l'épilepsie et la...


Sep 05, 2012, 04:00 ET NeuroSigma Receives CE Certification

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that it received CE Certification for its external Trigeminal Nerve...


May 08, 2012, 12:30 ET Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of...


Sep 06, 2011, 07:00 ET NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business...


Apr 28, 2011, 20:07 ET Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™

This afternoon, at the Antiepileptic Drug Trials XI Conference in Miami, Florida, (http://www.epilepsy.com/etp/aedtrialxi) Dr. Christopher...